BE-CAR33的1期可行性试验：一种用于急性髓系白血病的“现货型”碱基编辑CAR33 T细胞疗法

【原文标题】A phase 1 feasibility trial of BE-CAR33, an “off-the-shelf” base-edited CAR33 T cell therapy for acute myeloid leukemia